0.36
-5.11%
Close of 20 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $3.8m
- Last close × shares
- Volume
- 122k
- Shares, 20 Nov 2026
About cbdMD
From its filings with the US Securities and Exchange Commission
cbdMD is based in Charlotte, North Carolina and is incorporated in North Carolina. Its shares trade on NYSE under the ticker YCBD. The SEC classifies its business as perfumes, cosmetics & other toilet preparations. In the fiscal year to 30 September 2025, it reported revenue of $19.2m and a net loss of $2.0m. At that date it held total assets of $10.4m and shareholders' equity of $7.2m.
We operate a multi-brand portfolio anchored by our flagship cbdMD® line, which offers oils, gummies, capsules, soft-gels, topicals, functional formulations, and hemp-derived compliant Delta-9 THC products. Complementing this portfolio is Paw CBD®, our dedicated pet-wellness brand, which provides tinctures, chews, and topicals for dogs and cats and reflects our long-standing emphasis on safety and quality in the animal health category.
Our ATRX® platform offers cutting edge, emerging and novel non-cannabinoid functional ingredients such as functional mushrooms and supports future expansion into performance-driven nutraceutical and nootropic categories utilizing synergistic ingredient combinations.
Our Herbal Oasis (“Oasis”) brand is a premium hemp-derived THC-infused social seltzer that blends cannabinoids and nootropic mushrooms to deliver a fast-acting, functional beverage made for presence and connection.
Our products are sold through a diversified distribution network that includes direct-to-consumer e-commerce platforms, online marketplaces, wholesale distribution to national and regional retailers, specialty health and pet channels, and emerging international markets. This multi-channel strategy allows us to reach a broad and diverse consumer base, reduce reliance on any single distribution partner, and quickly introduce new products which reflect scientific findings, consumer trends, and regulatory dynamics.
Quoted from its 10-K, filed 19 Dec 2025. Read the filing on SEC.gov ↗
How it makes its money
Revenue, year to 30 Sept 2021
- E-commerce Sales $32.9m · 74.0%
- Wholesale Sales $11.6m · 26.0%
Latest on cbdMD
Our reporting
We have not reported on cbdMD yet.
Next results
Due on 18 Dec 2026. Analysts expect earnings of -0.09 a share.
Other Health Care listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is cbdMD's ticker?
cbdMD trades as YCBD on its US listing, under ISIN US12482W4087.
What was cbdMD's last closing price?
0.36 on 20 Nov 2026. The figure is in USD and is never converted.
When does cbdMD next report results?
Results are expected on 18 Dec 2026, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.